GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Wanbang Pharmaceutical Technology Co Ltd (SZSE:301520) » Definitions » Beginning Cash Position

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Beginning Cash Position : ¥253.5 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Anhui Wanbang Pharmaceutical Technology Co Beginning Cash Position?

Anhui Wanbang Pharmaceutical Technology Co's Beginning Cash Position for the quarter that ended in Mar. 2024 was ¥253.5 Mil.

Anhui Wanbang Pharmaceutical Technology Co's quarterly Beginning Cash Position increased from Sep. 2023 (¥170.6 Mil) to Dec. 2023 (¥1,051.7 Mil) but then declined from Dec. 2023 (¥1,051.7 Mil) to Mar. 2024 (¥253.5 Mil).

Anhui Wanbang Pharmaceutical Technology Co's annual Beginning Cash Position increased from Dec. 2021 (¥119.9 Mil) to Dec. 2022 (¥161.5 Mil) and increased from Dec. 2022 (¥161.5 Mil) to Dec. 2023 (¥186.2 Mil).

Anhui Wanbang Pharmaceutical Technology Co Beginning Cash Position Historical Data

The historical data trend for Anhui Wanbang Pharmaceutical Technology Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Wanbang Pharmaceutical Technology Co Beginning Cash Position Chart

Anhui Wanbang Pharmaceutical Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial 20.86 5.64 119.87 161.47 186.16

Anhui Wanbang Pharmaceutical Technology Co Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 186.16 159.90 170.56 1,051.68 253.50

Anhui Wanbang Pharmaceutical Technology Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Anhui Wanbang Pharmaceutical Technology Co Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Anhui Wanbang Pharmaceutical Technology Co's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Wanbang Pharmaceutical Technology Co Ltd (SZSE:301520) » Definitions » Beginning Cash Position
Comparable Companies
SZSE:002082 SZSE:000788 SZSE:300239 SHSE:603669 SZSE:002940 SZSE:000919 SHSE:603168 SZSE:002688 SZSE:002107 SZSE:002900 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
southwest corner of the intersection of Mingzhu Avenue and Huolongdi Road, Building 1, Anhui Wanbang Pharmaceutical, High-tech Zone, Anhui, Hefei, CHN, 230000
Website
http://www.ahwbyy.cn
Anhui Wanbang Pharmaceutical Technology Co Ltd is a one-stop CRO service platform that engages in the entire process from pharmaceutical development to clinical research of innovative drugs, improved new drugs and generic drugs. It aims to provide drug research and development and clinical trials for drug launch, including pharmaceutical research, clinical services, biological sample analysis and testing, SMO services and data statistics and analysis.

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Headlines

No Headlines